Call us
07971549402



Price:
Price 750 INR / Box
Minimum Order Quantity : 100 Boxes
Physical Form : Tablets
Storage Instructions : Store in a cool,dry&dark place . Protect from direct sunlight.
Ingredients : Telmisartan 40mg+ Hydrochlorothiazide 12.5 mg Tablet
Price 875.0 INR / Vial
Minimum Order Quantity : 100
Physical Form : Liquid
Storage Instructions : cool & dry place
Ingredients : Cefepime Hydrochloride 1000 mg + Tazobactam Sodium 125 mg Injection is a sterile powder vial combining fourthgeneration cephalosporin cefepime (1g) with betalactamase inhibitor tazobactam (125 mg) for IV/IM administration. Cefepime disrupts bacterial cell wall synthesis while tazobactam inhibits betalactamases, providing enhanced coverage against Gramnegative (Pseudomonas, Enterobacterales), Grampositive, and some anaerobes for complicated UTI, intraabdominal infections, pneumonia (including hospitalacquired), skin/soft tissue infections, and sepsis.
Price 43.09 INR / Vial
Minimum Order Quantity : 100
Physical Form : Liquid
Storage Instructions : cool & dry place
Ingredients : Noradrenaline Bitartrate equivalent to Noradrenaline 2mg is a sterile injectable concentrate (typically in 2mL ampoule) containing noradrenaline bitartrate providing 2mg noradrenaline base for dilution and continuous IV infusion via central line. Alpha1 agonist that increases mean arterial pressure by vasoconstriction (SBP/DBP rise >15mmHg target in septic shock), used for hypotensive states postfluid resuscitation including septic/distributive shock, cardiogenic shock, neurogenic hypotension.
Price 2775.0 INR / Strip
Minimum Order Quantity : 100
Physical Form : Tablets
Storage Instructions : cool & dry place
Ingredients : Tofacitinib 5 mg Tablet is a selective JAK1/3 inhibitor that blocks intracellular signaling pathways involved in inflammation, reducing cytokine production in rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and ulcerative colitis (UC). Used after inadequate response to DMARDs/TNF inhibitors; ORAL Standard trial showed ACR20 response 5965% vs. 2635% placebo at 3 months, with rapid onset (12 weeks) and sustained remission; also FDAapproved for polyarticular JIA 2 years.